首页> 外国专利> PLASMA MICRORNAS FOR THE DETECTION OF EARLY COLORECTAL CANCER.

PLASMA MICRORNAS FOR THE DETECTION OF EARLY COLORECTAL CANCER.

机译:血浆微RNA检测早期大肠癌。

摘要

The present invention relates in general to the field of colorectal cancer detection, and more particularly, to plasma microRNAs for the detection of early colorectal cancer. Specifically, the present invention includes methods, kits and biomarkers for diagnosing or detecting colorectal neoplasia in a human subject comprising the steps of: A method for diagnosing or detecting colorectal neoplasia in a human subject comprising the steps of: obtaining one or more biological samples from the subject suspected of suffering from colorectal neoplasia; measuring an overall expression pattern or level of one or more microRNAs obtained from the one or more biological samples of the subject; and comparing the overall expression pattern of the one or more microRNAs from the biological sample of the subject suspected of suffering from colorectal neoplasia with the overall expression pattern of the one or more microRNAs from a biological sample of a normal subject, wherein the normal subject is a healthy subject not suffering from colorectal neoplasia, wherein overexpression of a combination of miR19a and miR19b, or miR19a and miR19b and miR15b is indicative of colorectal cancer.
机译:本发明总体上涉及大肠癌检测领域,更具体地,涉及用于早期大肠癌检测的血浆微小RNA。具体地,本发明包括用于诊断或检测人类受试者的结直肠瘤形成的方法,试剂盒和生物标记物,包括以下步骤:用于诊断或检测人类受试者的结直肠瘤形成的方法,包括以下步骤:怀疑患有大肠肿瘤的受试者;测量从受试者的一种或多种生物学样品获得的一种或多种微RNA的总体表达模式或水平;并将疑似患有大肠肿瘤的受试者的一种或多种微小RNA的总体表达模式与正常受试者的一种或多种微RNA的总体表达模式进行比较,其中正常受试者是患有结直肠肿瘤的健康受试者,其中miR19a和miR19b或miR19a和miR19b和miR15b的组合的过表达指示结直肠癌。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号